Shanghai Universal Biotech Hits Day Low of CNY 30.03 Amid Price Pressure

Shanghai Universal Biotech Co., Ltd. experienced significant volatility on August 21, 2026, with the stock hitting an intraday low of CNY 30.03. The company, operating in the retailing sector, saw its stock decline by 10.04% for the day, contrasting sharply with the China Shanghai Composite's modest gain of 0.04%. Over the past week, Shanghai Universal Biotech has shown a slight increase of 0.59%, but its one-year performance remains concerning, with a decline of 9.62%. The company has struggled with profitability, as indicated by a low Return on Capital Employed (ROCE) of 9.65% and a negative net profit of CNY -21.91 million, reflecting a significant drop of 37.94%. The company's long-term growth prospects appear limited, with net sales growing at a mere 0.25% annually over the last five years. Additionally, the stock has consistently underperformed against the benchmark, with a three-year performance decline of 23.02%. With a market capitalization of CNY 1,246 million, Shanghai Universal Biotech continues to face challenges in its operational efficiency and financial stability.